Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.

Burgess, DC; Hunt, D; Li, L; Zannino, D; Williamson, E; Davis, TM; Laakso, M; Kesäniemi, YA; Zhang, J; Sy, RW; +3 more... Lehto, S; Mann, S; Keech, AC; (2009) Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. European heart journal, 31 (1). pp. 92-9. ISSN 0195-668X DOI: https://doi.org/10.1093/eurheartj/ehp377

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1093/eurheartj/ehp377

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar